Find A Lawyer
Near You

Contact us today for a complimentary consultation with a qualified attorney near you.

Trasylol Kidney Failure

The commonly prescribed heart surgery medication Trasylol (generic aprotinin) has been proven to cause Trasylol kidney failure among other severe side effects. The medication was released on the market in 1993 by pharmaceutical company Bayer AG, for the purpose of preventing excessive blood loss in patients undergoing cardiovascular surgical procedures. According a study released in January of 2006, in addition to Trasylol kidney failure, this antifibrinolytic agent nearly doubles the risk of death in heart surgery patients from 1.3 percent to 2.8 percent.

The Study

The study conducted to determine the risk of Trasylol kidney failure and other adverse side effects of Trasylol, was conducted by Dr. Dennis T. Mangano, in an effort to unveil longstanding safety concerns regarding the drug. The sampling included 4374 heart surgery patients of whom some were given Trasylol, and others were given generic alternatives or no medication at all.

The results found in patients taking Trasylol for blood loss control were unsettling. In comparison with those taking generic medications and no medications at all, the risk of for Trasylol kidney failure in patients taking the medication was nearly doubled.

What is Trasylol Kidney Failure?

Kidney failure is characterized by the inability of the body to filter waste and fluids leaving hazardous levels of excess in the body. Trasylol kidney failure can occur after any cardiovascular procedure whereby Trasylol is administered and the blood vessels or kidneys are blocked. Symptoms of Trasylol kidney failure may include bleeding of the stomach or intestines, fluid retention, confusion, seizures, and in severe cases, comas .

Trasylol kidney failure is a serious and potentially life threatening condition and in severe cases must be treated by dialysis . Dialysis operates as an artificial means of removing waste and excess fluid from the blood when the kidneys are compromised.

Serious Side Effects

In addition to Trasylol kidney failure, the medication displayed a number of other serious and significantly heightened risk factors. The risk for heart attack associated with the use of Trasylol is increased by approximately 50 percent. The risk of heart failure is increased by 109 percent and the risk of enduring a stroke caused by Trasylol is over 180 percent greater in comparison with other blood clotting medications.

Researchers estimate had Trasylol not been so widely used throughout the United States, healthcare costs could have been minimized by an estimated one billion dollars, and drug costs reduced by $250 million.

Alternative Medications

Findings of Dr. Mangano's research strongly support the use of alternate medications for the prevention of Trasylol kidney failure. Generic medications such as aminocaproic acid and tranexamic acid have proven to be equally effective, more economical and substantially less dangerous options for patients undergoing cardiovascular surgery.

Dr. Mangano has commented on his study, "In good conscience, I could not administer Trasylol to this group of patients, especially given the availability of safer alternatives."

Contact Us!

If you or a loved on has experienced a Trasylol kidney failure, you may be entitled to compensation for your pain and suffering. Contact us today to speak with a qualified personal injury attorney who can help you appreciate you legal rights. Our qualified Trasylol attorneys will evaluate your case; free of charge and help you determine a plan to protect your interests and capitalize your claims.

More Trasylol Resources